The FDA COVID vaccine policy has shifted significantly, bringing new regulations that could affect vaccine access for many Americans.With increased scrutiny on COVID-19 vaccines designed for individuals deemed low-risk, the agency asserts it will prioritize approvals for those at higher risk, such as adults over 65 or individuals with specific health factors.